Creación de un candidato terapéutico antiásmatico: sinergia entre biomisilar de omalizumab y agonsimo EP2

Mora Perez, Fernando de (Principal Investigator)
Godoy Olivares, Carlo Mauricio (Others)
Losada Fernández, Pedro (Others)
Costa Farré, Cristina (Collaborator)
Marco Valle, Alberto Jesus (Collaborator)
Picado, César (Investigator)

Sense entitat

Status	Finished
Effective start/end date	1/01/16 → 30/11/20

Funding

Institute of Health Carlos III (ISCIII): €128,865.00
European Regional Development Fund (FEDER)